Search all trials

Find therapies in clinical trials near you – page 33

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing ARV-471 and Palbociclib with Letrozole and Palbociclib for Patients with Estrogen Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Palbociclib

Contact Research Centre

Follicular lymphoma+2

Not recruiting

Registered drugNo placebo

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Haematological malignancy

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Clear cell renal cell carcinoma

Not recruiting

Registered drug

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Bladder transitional cell carcinoma+2

Not recruiting

Registered drugNo placebo

Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Brigatinib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Endometrial cancer+1

Not recruiting

Registered drugNo placebo

Study of Retifanlimab Alone and in Combination with Drug Therapy for Adults with Advanced or Metastatic Endometrial Cancer Who Have Not Responded to Platinum Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pemigatinib

Contact Research Centre

Find therapies in clinical trials near you – page 33

439 trials match your criteria

Breast cancer

Study Comparing ARV-471 and Palbociclib with Letrozole and Palbociclib for Patients with Estrogen Receptor Positive, HER2-Negative Advanced Breast Cancer

Follicular lymphoma+2

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Malignant melanoma

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Haematological malignancy

Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers

Non-small cell lung cancer

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Clear cell renal cell carcinoma

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Bladder transitional cell carcinoma+2

Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Non-small cell lung cancer+1

Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy

Non-small cell lung cancer

Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer

Myelofibrosis

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Non-small cell lung cancer

Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Endometrial cancer+1

Study of Retifanlimab Alone and in Combination with Drug Therapy for Adults with Advanced or Metastatic Endometrial Cancer Who Have Not Responded to Platinum Chemotherapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.